Bipolar Androgen Therapy in the Treatment of Prostate Cancer

被引:1
|
作者
Denmeade, Samuel Ray [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Oncol & Urol, Baltimore, MD 21218 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:408 / 411
页数:4
相关论文
共 50 条
  • [1] Bipolar Androgen Therapy in Prostate Cancer (Update)
    Lo, Eric M.
    Balasubramanian, Adithya
    Pastuszak, Alexander W.
    Khera, Mohit
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (05): : 831 - 834
  • [2] Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
    Denmeade, Samuel R.
    Sena, Laura A.
    Wang, Hao
    Antonarakis, Emmanuel S.
    Markowski, Mark C.
    ONCOLOGIST, 2023, 28 (06): : 465 - 473
  • [3] The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy
    Xie, Tao
    Song, Xian-Lu
    Wang, Chong
    Yu, Yu-Zhong
    Wang, Jing-Quan
    Chen, Zhe-Sheng
    Zhao, Shan-Chao
    DRUG DISCOVERY TODAY, 2021, 26 (05) : 1293 - 1301
  • [4] Bipolar Androgen Therapy: A Paradoxical Approach for the Treatment of Castration-resistant Prostate Cancer
    Schweizer, Michael T.
    Antonarakis, Emmanuel S.
    Denmeade, Samuel R.
    EUROPEAN UROLOGY, 2017, 72 (03) : 323 - 325
  • [5] Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer
    Isaacs, John T.
    Brennen, W. Nathaniel
    Denmeade, Samuel R.
    CELL CYCLE, 2017, 16 (18) : 1639 - 1640
  • [6] Bipolar androgen therapy for treatment of metastatic castration-resistant prostate cancer: A case series
    Tran, Elizabeth U.
    Ovruchesky, Eric
    Yamamoto, Kyra
    Marley, Samantha
    Song, Alexander
    Pan, Elizabeth
    Lee, Aaron M.
    Herchenhorn, Daniel
    Denmeade, Sam
    Antonarakis, Emmanuel S.
    Markowski, Mark
    Mckay, Rana R.
    PROSTATE, 2024,
  • [7] Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?
    Peinetti, Nahuel
    Bilusic, Marijo
    Burnstein, Kerry L.
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (23):
  • [8] Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives
    Leone, Gianmarco
    Buttigliero, Consuelo
    Pisano, Chiara
    Di Stefano, Rosario Francesco
    Tabbo, Fabrizio
    Turco, Fabio
    Vignani, Francesca
    Scagliotti, Giorgio Vittorio
    Di Maio, Massimo
    Tucci, Marcello
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 152
  • [9] Androgen replacement therapy after prostate cancer treatment
    Khera M.
    Current Urology Reports, 2010, 11 (6) : 393 - 399
  • [10] Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
    Sena, Laura A.
    Kumar, Rajendra
    Sanin, David E.
    Thompson, Elizabeth A.
    Rosen, D. Marc
    Dalrymple, Susan L.
    Antony, Lizamma
    Yang, Yuhan
    Gomes-Alexandre, Carolina
    Hicks, Jessica L.
    Jones, Tracy
    Bowers, Kiara A.
    Eskra, Jillian N.
    Meyers, Jennifer
    Gupta, Anuj
    Skaist, Alyza
    Yegnasubramanian, Srinivasan
    Luo, Jun
    Brennen, W. Nathaniel
    Kachhap, Sushant K.
    Antonarakis, Emmanuel S.
    De Marzo, Angelo M.
    Isaacs, John T.
    Markowski, Mark C.
    Denmeade, Samuel R.
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (23):